Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?
C. Bélizna(Centre Hospitalier Universitaire d'Angers), Katrien Devreese(Ghent University Hospital), Enrique Esteve‐Valverde(Althaia), Pascal Reynier(Centre National de la Recherche Scientifique), Christian Muchardt(Centre National de la Recherche Scientifique), Milena Hasan(Institut Pasteur), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), György Nagy(Semmelweis University), Loukman Omarjee(Université Nantes Angers Le Mans), Guillaume Mahé(Inserm), Laura Damian(Babeș-Bolyai University), Céline Fassot(Centre National de la Recherche Scientifique), Jan Willem Cohen-Tervaert(University of Alberta), Jaume Alijotas‐Reig(Universitat Autònoma de Barcelona), Alban Godon(Centre Hospitalier Universitaire d'Angers), Laurent Loufrani(Centre National de la Recherche Scientifique), Laurent Arnaud(Université Libre de Bruxelles), J Chrétien(Centre Hospitalier Universitaire d'Angers), Daniel Henrion(Université d'Angers), Ferdinando Nicoletti(University of Catania), Marc Antoine Pistorius(Centre Hospitalier Universitaire de Nantes), Marie Noëlle Ungeheuer(Institut Pasteur), Patrick Saulnier(Centre Hospitalier Universitaire d'Angers), Ljudmila Stojanovich(University of Belgrade)
Cited by 34
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913